In vivo evaluation of the neuroprotective effects of melittin on doxorubicin-induced acute and chronic neurotoxicity in mice
Brain Research · 2026-09 · 1887 · 150388
DOI: 10.1016/j.brainres.2026.150388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026-09. Verfasst von Soner Kina und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kafkas University, Faculty of Medicine Department of Anesthesiology and Reanimation, 36100 Kars, Türkiye. Electronic address: sonerkina2@gmail.com. Hauptthemen laut MEDLINE: Melitten, Doxorubicin, Neuroprotective Agents, Neurotoxicity Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Kafkas Üniversitesi.
Abstract (Originalsprache)
Doxorubicin (DOX) is a widely used chemotherapeutic agent whose clinical application is limited by severe neurotoxic side effects, manifesting as cognitive dysfunction and neuronal injury following both acute and chronic exposure. Neuroinflammation, oxidative stress, and apoptosis are central mechanisms underlying DOX-induced neurotoxicity. Melittin, a bioactive neuropeptide derived from bee venom, has demonstrated potent anti-inflammatory and cytoprotective properties; however, its effects on DOX-induced neurotoxicity remain insufficiently characterized. Mice were assigned to acute (DOX-4) and chronic (DOX-3) exposure protocols. Melittin was administered at doses of 0.1, 0.2, and 0.4 mg/kg. Neuroprotective efficacy was evaluated through biochemical markers of oxidative stress, including malondialdehyde (MDA) and reduced glutathione (GSH). Additionally, neuroinflammation (NF-κB, iNOS, nNOS, TNF-α, IL-6) and apoptosis (Caspase-3) were assessed via immunohistochemical and molecular analyses in brain tissue. In the present study, we investigated the neuroprotective effects of melittin in murine models of acute and chronic DOX-induced neurotoxicity. Male Balb/c mice were exposed to acute (4 mg/kg, 2 weeks) or chronic (3 mg/kg, 6 weeks) DOX administration, with melittin (0.1, 0.2, or 0.4 mg/kg) administered intraperitoneally prior to DOX administration. Molecular alterations were evaluated in brain tissue by quantitative real-time PCR analysis of NF-κB, TNF-α, IL-6, inducible and neuronal nitric oxide synthases (iNOS, nNOS), and caspase-3. Neuroprotective efficacy was evaluated through biochemical markers of oxidative stress, including malondialdehyde (MDA) and reduced glutathione (GSH). Finally, NF-κB protein expression was further assessed by immunohistochemistry. DOX administration significantly upregulated pro-inflammatory cytokines, NF-κB signaling, MDA level, iNOS and caspase-3 expression, while suppressing nNOS expression and GSH level in both acute and chronic neurotoxicity models. Melittin treatment markedly attenuated DOX-induced neuroinflammatory and apoptotic responses in a dose-dependent manner, with the highest dose restoring molecular parameters toward control levels. These protective effects were more pronounced in the chronic neurotoxicity model. Our findings demonstrate that melittin exerts a robust neuroprotective effect by modulating the oxidative-inflammatory-apoptotic axis and restoring redox homeostasis in the brain. Melittin may represent a promising neuropeptide-based therapeutic strategy for mitigating chemotherapy-associated neurotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kafkas University, Faculty of Medicine Department of Anesthesiology and Reanimation, 36100 Kars, Türkiye. Electronic address: sonerkina2@gmail.com.
- Kafkas University, Faculty of Medicine Department of Histology and Embryology, 36100 Kars, Türkiye. Electronic address: selin.atauni@hotmail.com.
Förderung
- Kafkas Üniversitesi
Zitieren
APA
Kina, S., & Karamese, S. A. (2026). In vivo evaluation of the neuroprotective effects of melittin on doxorubicin-induced acute and chronic neurotoxicity in mice. Brain Research, 1887, 150388. https://doi.org/10.1016/j.brainres.2026.150388
Vancouver
Kina S, Karamese SA. In vivo evaluation of the neuroprotective effects of melittin on doxorubicin-induced acute and chronic neurotoxicity in mice. Brain Research. 2026;1887:150388. doi:10.1016/j.brainres.2026.150388
BibTeX
@article{Kina2026,
author = {Kina, Soner and Karamese, Selina Aksak},
title = {In vivo evaluation of the neuroprotective effects of melittin on doxorubicin-induced acute and chronic neurotoxicity in mice},
journal = {Brain Research},
year = {2026},
volume = {1887},
pages = {150388},
doi = {10.1016/j.brainres.2026.150388}
}
EUVIMED